1 / 12

Europe Viscosupplementation Market

Future Market Insights (FMI) offers a 10-year forecast of the Europe viscosupplementation market between 2016 and 2026. In terms of value, the market is expected to register a CAGR of 5.1% over the forecast period. This study demonstrates market dynamics and trends that influence the current environment and future status of the viscosupplementation market in Europe over the forecast period.<br>Report Description<br>This Future Market Insights report examines the Europe viscosupplementation market for the period 2016u20132026. The primary objective of the report is to offer insights on various viscosupplementation products such as single injection viscosupplementation, three injection viscosupplementation and five injection Viscosupplementation. The report also covers product pipeline analysis to understand market dynamics and patients preference for various product types.<br>This report begins by defining various viscosupplementation product types and top brands in the market. It is followed by an overview of market dynamics of the Europe viscosupplementation market, which includes FMI analysis of key trends, drivers, restraints and opportunities, regulations, drug pipeline analysis and key players (includes clinical trials and major players and their projects in the pipeline). It also includes an insight into product pricing by regions, highlighting regional pricing dynamics and reimbursement scenario. Impact analyses of key growth drivers and restraints based on the weighted average model have been included in the viscosupplementation market report after analysis of individual regions to better equip readers with meaningful insights on ongoing developments in the market.<br>Primary factors fuelling demand for viscosupplementation are rapidly ageing population with osteoarthritis indication, strong safety profile and excellent physiochemical properties of hyaluronic acid-based viscosupplementation injections. Other factors driving demand for viscosupplementation are rising obesity rates and the cost-effectiveness of treatment. As per a survey, the estimated annual medical cost of Osteoarthritis care per patient ranges from US$ 1,498.67 Mn to US$ 11,777.5 Mn over 2000u20132012.<br>Viscosupplementation intra-articular injections, with advanced safety profile, excellent physiochemical and anti-inflammatory properties, help in restoration of synovial fluid elasticity. On the contrary, factors such as reimbursement cutbacks and regional competition among local players in EU countries are expected to hamper market growth in the near future.<br>To Get Sample Copy of Report visit @https://www.futuremarketinsights.com/reports/sample/rep-eu-1383<br>Based on product type, the market has been segmented into single injection viscosupplementation, three injection viscosupplementation and five injection viscosupplementation. A detailed analysis has been provided for every segment in terms of average pricing analysis, market size, Y-o-Y growth rate, absolute $ opportunity and BPS analysis.<br>Further, on the basis of end users, hospitals segment is expected to witness significant demand for viscosupplementation over the forecast period. This trend is expected to be particularly prominent in Western European countries, which are increasing access to healthcare services. However, orthopedic clinics segment is expected to exhibit the highest growth over the forecast period.<br>The next section of the report highlights the viscosupplementation market in Europe and provides market outlook for 2016u20132026 in terms of market size, Y-o-Y growth rates, absolute $ opportunity and BPS analysis. Key regions assessed in this report are Western Europe and Eastern Europe.<br>The above sectionsu2014by product type, end users and regionu2014evaluate the present scenario and growth prospects of the Europe viscosupplementation market for 2016u20132026. We have considered 2014 as the base year and provided data for the forecast period.<br>In addition, it is imperative to note that in an ever-fluctuating European economy, we not only conduct forecasts in terms of CAGR, but also provide analysis based on key parameters such as year-on-year (Y-o-Y) growth rates to understand the predictability of the market and to identify the right opportunities across the viscosupplementation market.<br>The viscosupplementation market in terms of product, end users and regions are analysed in terms of Basis Point Share (BPS) to understand individual segmentu2019s relative contributions to market growth. This detailed level of information is important for identifying various key trends in the viscosupplementation market.<br>Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective of the viscosupplementation market. <br>In the final section of the report, competitive landscape of the viscosupplementation market is included to provide report audiences with a dashboard view, based on categories of providers in in the value chain, their product portfolio and key differentiators. Key categories of providers covered in the report are manufacturers of hyaluronic acid injections. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the viscosupplementation value chain and potential players for the same. Report audiences can gain segment-specific vendor insights to identify and evaluate key competitors based on in-depth assessment of capabilities and successes in the viscosupplementation market.<br>Detailed profiles of the providers are also included in the scope of the report to evaluate their long-term and short-term strategies, key offerings, SWOT analysis and recent developments in the viscosupplementation market. Key manufacturers included in the report are Anika Therapeutics Inc., Sanofi S.A., Zimmer Biomet Holdings, Meda AB, Ferring B.V, Fidia Pharmaceutici S.p.A and Bioventus LLC.<br>Key Segments<br>u2022tProduct Type<br>otSingle Injection Viscosupplementation<br>otThree Injection Viscosupplementation<br>otFive Injection Viscosupplementation<br>u2022tEnd User<br>otHospitals<br>otAmbulatory Surgical Centres<br>otOrthopaedic Clinics<br>Request for Analysis @ https://www.futuremarketinsights.com/ask-question/rep-eu-1383<br> Key Regions/Countries<br>u2022tWestern Europe<br>otU.K.<br>otFrance<br>otGermany<br>otSpain<br>otItaly<br>otNordics<br>otRest of Western Europe<br>u2022tEastern Europe<br>otRussia<br>otRest of Eastern Europe<br>Key Companies<br>u2022tBraun Melsungen AG.<br>u2022tAnika Therapeutics Inc.<br>u2022tSanofi S.A.<br>u2022tZimmer Biomet Holdings<br>u2022tMeda AB<br>u2022tFerring B.V<br>u2022tFidia Pharmaceutici S.p.A<br>u2022tBioventus LLC.<br>About us:<br>Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.<br>Contact<br>Mr. Abhishek Budholiya<br>Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,<br>Jumeirah Lakes Towers, Dubai,<br>United Arab Emirates<br>MARKET ACCESS DMCC Initiative<br>For Sales Enquiries: sales@futuremarketinsights.com<br>For Media Enquiries: press@futuremarketinsights.com<br><br>

Download Presentation

Europe Viscosupplementation Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Europe Viscosupplementation Market www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights © 2019 Future Market Insights, All Rights Reserved January 2020 Report Id : REP-EU-1383 Published On : 2016-04-12 Category : Healthcare, Pharmaceuticals & Medical Devices

  2. AboutFuture Market Insights Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Research Capabilities Sector Coverage • Customized Research • Syndicated Research • Investment Research • Social Media Research • Automotive and Transportation • Electronics, Semiconductor, and ICT • Retail and Consumer Products • Industrial Automation and Equipment • Chemicals & Materials • Food and Beverages • Services and Utilities • Energy, Mining, Oil, and Gas Customized Research Syndicated Research Investment Research Social Media Research Subscription Information For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com

  3. Research Methodology (1/2) Research & Intelligence Data Collection Actionable Insights Data Filter & Analysis Business Solution 1 Market profiling 2 Formulating discussion guide • Identifying key opinion leaders • Questionnaire design • In-depth interviews • Coverage across value chain 3 A Developing list of respondents • Key industry experts • Channel study • Developments • Market dynamics • Products • Conclusions Primary Research 4 SOLUTION Data collection • Market participants • Key strengths • Product portfolio • Mapping as per value chain • Key focus segments B 5 Desk Research Data validation 6 C Data analysis Primary Research # • Secondary Research # • Paid Publications# Company Analysis • Linkedin • Zoominfo • Salesforce • Avention • Company websites • Company annual reports • White papers • Financial reports • Factiva • GBI • Genios • Meltwater 7 Insights Systematic Research Approach # includes sources of databases

  4. Europe Viscosupplementation MarketAnalysis Future Market Insights (FMI) offers a 10-year forecast of the Europe viscosupplementation market between 2016 and 2026. In terms of value, the market is expected to register a CAGR of 5.1% over the forecast period. This study demonstrates market dynamics and trends that influence the current environment and future status of the viscosupplementation market in Europe over the forecast period. Report Description This Future Market Insights report examines the Europe viscosupplementation market for the period 2016–2026. The primary objective of the report is to offer insights on various viscosupplementation products such as single injection viscosupplementation, three injection viscosupplementation and five injection Viscosupplementation. The report also covers product pipeline analysis to understand market dynamics and patients preference for various product types. This report begins by defining various viscosupplementation product types and top brands in the market. It is followed by an overview of market dynamics of the Europe viscosupplementation market, which includes FMI analysis of key trends, drivers, restraints and opportunities, regulations, drug pipeline analysis and key players (includes clinical trials and major players and their projects in the pipeline).  It also includes an insight into product pricing by regions, highlighting regional pricing dynamics and reimbursement scenario. Impact analyses of key growth drivers and restraints based on the weighted average model have been included in the viscosupplementation market report after analysis of individual regions to better equip readers with meaningful insights on ongoing developments in the market.

  5. Europe Viscosupplementation MarketAnalysis Primary factors fuelling demand for viscosupplementation are rapidly ageing population with osteoarthritis indication, strong safety profile and excellent physiochemical properties of hyaluronic acid-based viscosupplementation injections. Other factors driving demand for viscosupplementation are rising obesity rates and the cost-effectiveness of treatment. As per a survey, the estimated annual medical cost of Osteoarthritis care per patient ranges from US$ 1,498.67 Mn to US$ 11,777.5 Mn over 2000–2012. Viscosupplementation intra-articular injections, with advanced safety profile, excellent physiochemical and anti-inflammatory properties, help in restoration of synovial fluid elasticity. On the contrary, factors such as reimbursement cutbacks and regional competition among local players in EU countries are expected to hamper market growth in the near future. To Get Sample Copy of Report visit @https://www.futuremarketinsights.com/reports/sample/rep-eu-1383 Based on product type, the market has been segmented into single injection viscosupplementation, three injection viscosupplementation and five injection viscosupplementation.  A detailed analysis has been provided for every segment in terms of average pricing analysis, market size, Y-o-Y growth rate, absolute $ opportunity and BPS analysis.

  6. Europe Viscosupplementation MarketAnalysis Further, on the basis of end users, hospitals segment is expected to witness significant demand for viscosupplementation over the forecast period. This trend is expected to be particularly prominent in Western European countries, which are increasing access to healthcare services. However, orthopedic clinics segment is expected to exhibit the highest growth over the forecast period. The next section of the report highlights the viscosupplementation market in Europe and provides market outlook for 2016–2026 in terms of  market size, Y-o-Y growth rates, absolute $ opportunity and BPS analysis.  Key regions assessed in this report are Western Europe and Eastern Europe. The above sections—by product type, end users and region—evaluate the present scenario and growth prospects of the Europe viscosupplementation market for 2016–2026. We have considered 2014 as the base year and provided data for the forecast period. In addition, it is imperative to note that in an ever-fluctuating European economy, we not only conduct forecasts in terms of CAGR, but also provide analysis based on key parameters such as year-on-year (Y-o-Y) growth rates to understand the predictability of the market and to identify the right opportunities across the viscosupplementation market.

  7. Europe Viscosupplementation MarketAnalysis The viscosupplementation market in terms of product, end users and regions are analysed in terms of Basis Point Share (BPS) to understand individual segment’s relative contributions to market growth. This detailed level of information is important for identifying various key trends in the viscosupplementation market. Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective of the viscosupplementation market.  In the final section of the report, competitive landscape of the viscosupplementation market is included to provide report audiences with a dashboard view, based on categories of providers in in the value chain, their product portfolio and key differentiators. Key categories of providers covered in the report are manufacturers of hyaluronic acid injections. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the viscosupplementation value chain and potential players for the same. Report audiences can gain segment-specific vendor insights to identify and evaluate key competitors based on in-depth assessment of capabilities and successes in the viscosupplementation market.

  8. Europe Viscosupplementation MarketAnalysis • Detailed profiles of the providers are also included in the scope of the report to evaluate their long-term and short-term strategies, key offerings, SWOT analysis and recent developments in the viscosupplementation market. Key manufacturers included in the report are Anika Therapeutics Inc., Sanofi S.A., Zimmer Biomet Holdings, Meda AB, Ferring B.V, FidiaPharmaceutici S.p.A and Bioventus LLC. • Key Segments • Product Type • Single Injection Viscosupplementation • Three Injection Viscosupplementation • Five Injection Viscosupplementation • End User • Hospitals • Ambulatory Surgical Centres • OrthopaedicClinics

  9. Europe Viscosupplementation MarketAnalysis • Request for Analysis @ https://www.futuremarketinsights.com/ask-question/rep-eu-1383 •  Key Regions/Countries • Western Europe • U.K. • France • Germany • Spain • Italy • Nordics • Rest of Western Europe • Eastern Europe • Russia • Rest of Eastern Europe

  10. Europe Viscosupplementation MarketAnalysis • Key Companies • Braun Melsungen AG. • Anika Therapeutics Inc. • Sanofi S.A. • Zimmer Biomet Holdings • Meda AB • Ferring B.V • FidiaPharmaceutici S.p.A • Bioventus LLC.

  11. Europe Viscosupplementation MarketAnalysis ABOUT US: Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers. For more insights on the Europe Viscosupplementation Market,you can request a report sample with full TOC

  12. To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com For media queries, contact the press office at press@futuremarketinsights.com For other queries contact:Hari. T (Sr. Manager - Global Business Development) Future Market Insights: 3rd Floor,207 Regent Street, London W1B 3HH T: +44 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Thank You Future Market Insights Global & Consulting Private Limited (FMI)

More Related